Clinical and biological relevance of statin-mediated changes in HDL metabolism

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Pharmacology

Background:

• Low high-density lipoprotein (HDL) cholesterol is a known cardiovascular risk factor.
• The role of HDL cholesterol in patients achieving optimal low-density lipoprotein (LDL) cholesterol with statin therapy remains uncertain.
• The impact of statin-induced changes in HDL on cardiovascular risk requires further clarification.

Purpose of the Study:

• To review evidence on statin therapy's modulation of HDL metabolism.
• To investigate the relationship between HDL parameters and cardiovascular risk in statin-treated patients.
• To explore the effect of statins on HDL particle characteristics and function.

Main Methods:

• Systematic review of epidemiological studies.
• Analysis of clinical trial data.
• Examination of experimental research on HDL metabolism.

Main Results:

• Prospective studies link low HDL cholesterol to increased cardiovascular risk.
• Statin therapy's effect on HDL cholesterol levels is minimal, but it significantly alters HDL particle size, concentration, and function.
• Evidence suggests statins may influence HDL metabolism and reverse cholesterol transport.

Conclusions:

• Statin therapy may impact cardiovascular risk through mechanisms beyond LDL reduction, potentially involving HDL modulation.
• Further research is needed to elucidate the clinical significance of statin-induced HDL changes.
• Understanding statin's effects on HDL metabolism is crucial for optimizing cardiovascular disease prevention.